Akero Therapeutics, Inc is a biotechnology business based in the US. Akero Therapeutics shares (AKRO) are listed on the NASDAQ and all prices are listed in US Dollars. Akero Therapeutics employs 21 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Akero Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AKRO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Akero Therapeutics stock price (NASDAQ: AKRO)Use our graph to track the performance of AKRO stocks over time.
Akero Therapeutics shares at a glance
|Latest market close||$26.18|
|52-week range||$21.34 - $38.26|
|50-day moving average||$26.52|
|200-day moving average||$28.62|
|Wall St. target price||$60.86|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-91.75|
Buy Akero Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Akero Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Akero Therapeutics price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||-5.28%|
|3 months (2021-04-26)||-13.34%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Akero Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-26.97%|
|Return on equity TTM||-45.24%|
|Market capitalisation||$800 million|
TTM: trailing 12 months
Shorting Akero Therapeutics shares
There are currently 3.4 million Akero Therapeutics shares held short by investors – that's known as Akero Therapeutics's "short interest". This figure is 3.7% up from 3.3 million last month.
There are a few different ways that this level of interest in shorting Akero Therapeutics shares can be evaluated.
Akero Therapeutics's "short interest ratio" (SIR)
Akero Therapeutics's "short interest ratio" (SIR) is the quantity of Akero Therapeutics shares currently shorted divided by the average quantity of Akero Therapeutics shares traded daily (recently around 281141.5372036). Akero Therapeutics's SIR currently stands at 12.23. In other words for every 100,000 Akero Therapeutics shares traded daily on the market, roughly 12230 shares are currently held short.
However Akero Therapeutics's short interest can also be evaluated against the total number of Akero Therapeutics shares, or, against the total number of tradable Akero Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akero Therapeutics's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Akero Therapeutics shares in existence, roughly 100 shares are currently held short) or 0.1897% of the tradable shares (for every 100,000 tradable Akero Therapeutics shares, roughly 190 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Akero Therapeutics.
Find out more about how you can short Akero Therapeutics stock.
Akero Therapeutics share dividends
We're not expecting Akero Therapeutics to pay a dividend over the next 12 months.
Akero Therapeutics share price volatility
Over the last 12 months, Akero Therapeutics's shares have ranged in value from as little as $21.34 up to $38.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akero Therapeutics's is 0.5197. This would suggest that Akero Therapeutics's shares are less volatile than average (for this exchange).
Akero Therapeutics overview
Akero Therapeutics, Inc. , a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. Its lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018.
Stocks similar to Akero Therapeutics
Akero Therapeutics in the news
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Akero Therapeutics Appoints Judy Chou, Ph.D., to its Board of Directors
Frequently asked questionsWhat percentage of Akero Therapeutics is owned by insiders or institutions?
Currently 23.143% of Akero Therapeutics shares are held by insiders and 81.326% by institutions. How many people work for Akero Therapeutics?
Latest data suggests 21 work at Akero Therapeutics. When does the fiscal year end for Akero Therapeutics?
Akero Therapeutics's fiscal year ends in December. Where is Akero Therapeutics based?
Akero Therapeutics's address is: 601 Gateway Boulevard, South San Francisco, CA, United States, 94080 What is Akero Therapeutics's ISIN number?
Akero Therapeutics's international securities identification number is: US00973Y1082 What is Akero Therapeutics's CUSIP number?
Akero Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00973Y108
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert